Health and Human Services Secretary Robert F. Kennedy Jr. testified that vaccines are exempt from pre-licensure safety studies. Is it actually the case that vaccines are approved without safety ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Languages: English The United States Food and Drug Administration (FDA) has approved another vaccine maker to create a shot to help prevent COVID-19, with caveats. Newsweek has reached out to ...

A former TCS employee has thanked the IT services company for changing his life (Representational image) “Whatever little I have today in life I owe it to TCS,” Sriram wrote in a post shared ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...

TCS stated that BSNL will issue detailed purchase orders in due course, subject to certain conditions and documentation being fulfilled. Tata Consultancy Services (TCS), India’s largest IT ...

Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday that his agency would no longer recommend the coronavirus vaccine for healthy pregnant women and healthy children — an ...

"I couldn't be more pleased to announce that, as of today, the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC's recommended immunization schedule ...

The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about the risk of a possible heart injury side effect linked to the mRNA ...

The country’s largest IT services company, TCS, has split its AI.Cloud business unit into two dedicated verticals, eyeing higher growth from untapped market potential, a senior official has said.

TCS is also investing in specialist AI talent and training programs to enhance its capabilities and offer integrated AI-data solutions to clients. Company officials noted that the decision to ...

The company also received regulatory approval to begin phase 2 clinical trials for its bivalent TCV vaccine in the March quarter. “...with potential access now to both India’s public [market ...